258
Views
9
CrossRef citations to date
0
Altmetric
Review

Profile of crizanlizumab and its potential in the prevention of pain crises in sickle cell disease: evidence to date

&
Pages 307-311 | Published online: 30 Aug 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.